The congress had 1,816 registered participants, 1216 abstracts presented
(1083 published in Tox Letter and 133 in addenda), 50 sessions (6
plenary lectures, 28 symposia, 7 workshops, 3 days posters in 27
sections, 6 training courses), 150 exhibitors from 64 companies/entities
(6 non profit entities), 180 invited speakers/chairs/course-teachers.
IUTOX-2010 was the XII International Congress of Toxicology (ICT-XII), the congress of the International Union of Toxicology (IUTOX)
The Congress organizers encouraged the interaction between Academia, Industry, Regulators, Expert in Human (clinical and epidemiology) and Environmental Toxicology.
Chemical Safety is increasingly requiring integrated and translational approaches to get successful possibilities of innovative application of the results of research and development based on added values with safety to human health and the environment. From the most basic molecular and cellular research, going through in vitro alternative approach of understanding long term effects, “omics” strategist for in vitro and more rational animal testing and human diagnosis, application of human data (epidemiological and clinical data) to risk assessment in regulatory purpose, alternative efficient strategists for toxicity evaluation and computing data handling, efficient process for realistic risk characterization of thousands of chemicals, risk communication and social acceptance. All these different levels of activities need to be integrated in translational approaches for successful industrial, biomedical and environmental applications. New material as nanomaterials and new drug generations and biotechnological products and the objectives of sustainable chemistry open to new scientific and methodological approaches.
The IUTOX-2010 was a forum for interaction among different fields of activity related with toxicology under a scientific environment.
Multidisciplinary and translational approaches for interacting expert from academia (basis mechanistic, effects testing, monitoring), industry, clinical toxicologists, environmentalists, regulators, and technological developers, will be especially welcome.